Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC von Mok, T.S.K., Lopes, G., Cho, B.C., Kowalski, D.M., Kasahara, K., Wu, Y.-L., de Castro, G., Turna, H.Z., Cristescu, R., Aurora-Garg, D., Loboda, A., Lunceford, J., Kobie, J., Ayers, M., Pietanza, M.C., Piperdi, B., Herbst, R.S.

Volltext

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients von de Azambuja, E, Cardoso, F, de Castro, G, Colozza, M, Mano, M S, Durbecq, V, Sotiriou, C, Larsimont, D, Piccart-Gebhart, M J, Paesmans, M

Volltext

Randomised phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with OV versus gemcitabine (GEM) and P followed by maintenance with GEM as first-line c... von Grossi, F., Jaskiewicz, P., Pichon, E., Czyzewicz, G., Kowalski, D.M., Ciuffreda, L., Garcia Gomez, R., Caruso, S., Bosch Barrera, J., Ta Thanh Minh, C., Gautier, S., Hervieu, H., Henriet, S., De Castro Jr, G.

Volltext

The wolf in sheep's clothing: Microtomographic aspects of clinically incipient radiation-related caries von Morais-Faria, K, Neves-Silva, R, Lopes, M-A, Ribeiro, A-C-P, de Castro, Jr, G, da Conceição-Vasconcelos, K-G-M, Brandão, T-B, Santos-Silva, A-R

Volltext

Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 von Cocks, K, King, M.T, Velikova, G, de Castro, G, Martyn St-James, M, Fayers, P.M, Brown, J.M

Volltext

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial von Herbst, R.S., Baas, P., Perez-Gracia, J.L., Felip, E., Kim, D.-W., Han, J.-Y., Molina, J.R., Kim, J.-H., Dubos Arvis, C., Ahn, M.-J., Majem, M., Fidler, M.J., Surmont, V., de Castro, G., Garrido, M., Shentu, Y., Emancipator, K., Samkari, A., Jensen, E.H., Lubiniecki, G.M., Garon, E.B.

Volltext

Impact of the COVID-19 Outbreak on Cancer Staging in Brazil von de Sousa, C.F.P.M., de Castro Junior, G., Starling, M.T.M., Restini, F.C.F., Rodrigues, A.N., de Castro Ribeiro, H.S., Arruda, G.V., Hanna, S.A., de Moraes, F.Y., Marta, G.N.

Volltext

Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN) von Launay-Vacher, V., Aapro, M., De Castro, G., Cohen, E., Deray, G., Dooley, M., Humphreys, B., Lichtman, S., Rey, J., Scotté, F., Wildiers, H., Sprangers, B.

Volltext

VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC von Hochmair, M.J., Vermaelen, K., Mountzios, G., Carcereny, E., Dooms, C., Lee, S-H., Morocz, E.M., Kato, T., Ciuleanu, T-E., Dy, G., Parente, M.B.M.C.S., O'Byrne, K.J., Chu, Q.S-C., De Castro, G., Girard, N., Snyder, W., Tran, Q., Kormany, W., Houk, B., Curioni-Fontecedro, A.

Volltext

997P STK11 and KEAP1 mutational status and their impact in survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors: Meta-analyses of clin... von de Castro Jr, G., Kashiura, D., Harada, G., Lima Torres, L., Codima, A., Monteiro, G., Costa, I.G., Julian, G.S.

Volltext

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) von Burtness, B., Harrington, K.J., Greil, R., Soulières, D., Tahara, M., De Castro, G., Psyrri, A., Baste Rotllan, N., Neupane, P.C., Bratland, Å, Fuereder, T., Hughes, B.G.M., Mesia, R., Ngamphaiboon, N., Rordorf, T., Wan Ishak, W.Z., Roy, A., Cheng, J., Jin, F., Rischin, D.

Volltext

VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC von Hochmair, M.J, Vermaelen, K, Mountzios, G, Carcereny, E, Dooms, C, Lee, S.-H, Morocz, E.M, Kato, T, Ciuleanu, T.-E, Dy, G, Parente, M.B.M.C.S, O'Byrne, K.J, Chu, Q.S.-C, De Castro Jr, G, Girard, N, Snyder, W, Tran, Q, Kormany, W, Houk, B, Curioni-Fontecedro, A

Volltext

Final Analysis of the Phase 4 KEYNOTE-B10 Study: First-Line (1L) Pembrolizumab (pembro) + Carboplatin (carbo) + Paclitaxel (pacli) for Recurrent/Metastatic (R/M) Head and Neck Squa... von Dzienis, M., Cundom, J., Fuentes, C.S., Spreafico, A., Nordlinger, M.J., Pastor, A.V., Alesi, E., Neki, A., Fung, A.S., Lima, I.P. Figueiredo, Oppelt, P., Junior, G.F. da Cunha, Franke, F.A., Tseng, J., Joshi, A.J., McCarthy, J., Sidi, Y., Gumuscu, B., Naicker, N., Jr, G. de Castro

Volltext

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial von Clement, P.M., Gauler, T., Machiels, J.P., Haddad, R.I., Fayette, J., Licitra, L.F., Tahara, M., Cohen, E.E.W., Cupissol, D., Grau, J.J., Guigay, J., Caponigro, F., de Castro, G., de Souza Viana, L., Keilholz, U., del Campo, J.M., Cong, X.J., Ehrnrooth, E., Vermorken, J.B.

Volltext

Fecal microbiota transplant after hematopoietic SCT: report of a successful case von de Castro, C G, Ganc, A J, Ganc, R L, Petrolli, M S, Hamerschlack, N

Volltext

Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042 von Nosaki, K., Hosomi, Y., Saka, H., Baas, P., de Castro, G., Reck, M., Wu, Y.-L., Brahmer, J.R., Felip, E., Sawada, T., Noguchi, K., Han, S.R., Piperdi, B., Kush, D.A., Lopes, G.

Volltext

Efficacy and safety of adjuvant chemotherapy in lung cancer: Real-world evidence von Roitberg, F.S.R., Neffá, M.F.B.V., Bonadio, R.R.C.C., Harada, G., Mendoza, E.Z., Mak, M.P., Takahashi, T.K., Martins, R.E., Mesquita, C., Santini, F.C., de Araújo, P.H.X.N., Lauricella, L.L., Prado, G.F., Takagaki, T.Y., de Mello, E.S., Gabrielli, F., de Andrade Carvalho, H.D.A., Terra, R.M., de Castro, G.

Volltext

Degree of Knowledge of Health Care Professionals About Pain Management and Use of Opioids in Pediatrics von Freitas, Gabriel R. M., Castro, Cláudio G., Castro, Stela M. J., Heineck, Isabela

Volltext

Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive lo... von Mok, T.S.K, Wu, Y.-L., Kudaba, I., Kowalski, D.M., Cho, B.C., Turna, H.Z., de Castro, G., Srimuninnimit, V., Laktionov, K.K., Bondarenko, I., Kubota, K., Caglevic, C., Karaszewska, B., Dang, T., Yin, L., Penrod, J., Lopes, G.

Volltext

1440PRandomised phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with OV versus gemcitabine (GEM) and P followed by maintenance with GEM as first-l... von Grossi, F, Jaskiewicz, P, Pichon, E, Czyzewicz, G, Kowalski, D M, Ciuffreda, L, Garcia Gomez, R, Caruso, S, Bosch Barrera, J, Ta Thanh Minh, C, Gautier, S, Hervieu, H, Henriet, S, De Castro Jr, G

Volltext